WATANABE, Yoshihiko, Germaine CORNÉLISSEN, Franz HALBERG, Larry BEATY, Jarmila SIEGELOVÁ, Kuniaki OTSUKA and Earl E. BAKKEN. HARM VS. BENEFIT FROM LOSARTAN WITH HYDROCHLOROTHIAZIDE AT DIFFERENT CIRCADIAN TIMES IN MESOR-HYPERTENSION OR CHAT. In Noninvasive methods in cardiology. Brno: NCO NZO v Brně, MU Brno, 2008, p. 149-167. první vydání. ISBN 978-80-7013-481-8.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name HARM VS. BENEFIT FROM LOSARTAN WITH HYDROCHLOROTHIAZIDE AT DIFFERENT CIRCADIAN TIMES IN MESOR-HYPERTENSION OR CHAT
Name in Czech Poškození nebo prospěch z léčby losartanem a hydrochlorothiazide v různých časech dne u pacientů s mesorovnou hypertenzí nebo hyperamplitudovou hypertenzí
Authors WATANABE, Yoshihiko, Germaine CORNÉLISSEN, Franz HALBERG, Larry BEATY, Jarmila SIEGELOVÁ, Kuniaki OTSUKA and Earl E. BAKKEN.
Edition Brno, Noninvasive methods in cardiology, p. 149-167, 19 pp. první vydání, 2008.
Publisher NCO NZO v Brně, MU Brno
Other information
Original language English
Type of outcome Chapter(s) of a specialized book
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
ISBN 978-80-7013-481-8
Keywords in English LOSARTAN;HYDROCHLOROTHIAZIDE;MESOR-HYPERTENSION ;CHAT
Tags CHAT, HYDROCHLOROTHIAZIDE, losartan, MESOR-hypertension
Changed by Changed by: Ing. Soňa Hanzelková, učo 107137. Changed: 29/4/2009 10:19.
Abstract
HARM VS. BENEFIT FROM LOSARTAN WITH HYDROCHLOROTHIAZIDE AT DIFFERENT CIRCADIAN TIMES IN MESOR-HYPERTENSION OR CHAT
Abstract (in Czech)
Poškození nebo prospěch z léčby losartanem a hydrochlorothiazide v různých časech dne u pacientů s mesorovnou hypertenzí nebo hyperamplitudovou hypertenzí
Links
MSM0021622402, plan (intention)Name: Časná diagnostika a léčba kardiovaskulárních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Early diagnostics and treatment of cardiovascular diseases
PrintDisplayed: 13/5/2024 14:30